152 related articles for article (PubMed ID: 22515525)
1. anti-tumor effect of AlkB homolog 3 knockdown in hormone- independent prostate cancer cells.
Koike K; Ueda Y; Hase H; Kitae K; Fusamae Y; Masai S; Inagaki T; Saigo Y; Hirasawa S; Nakajima K; Ohshio I; Makino Y; Konishi N; Yamamoto H; Tsujikawa K
Curr Cancer Drug Targets; 2012 Sep; 12(7):847-56. PubMed ID: 22515525
[TBL] [Abstract][Full Text] [Related]
2. ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer.
Tasaki M; Shimada K; Kimura H; Tsujikawa K; Konishi N
Br J Cancer; 2011 Feb; 104(4):700-6. PubMed ID: 21285982
[TBL] [Abstract][Full Text] [Related]
3. PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis.
Yamato I; Sho M; Shimada K; Hotta K; Ueda Y; Yasuda S; Shigi N; Konishi N; Tsujikawa K; Nakajima Y
Cancer Res; 2012 Sep; 72(18):4829-39. PubMed ID: 22826605
[TBL] [Abstract][Full Text] [Related]
4. ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.
Shimada K; Fujii T; Tsujikawa K; Anai S; Fujimoto K; Konishi N
Clin Cancer Res; 2012 Oct; 18(19):5247-55. PubMed ID: 22850567
[TBL] [Abstract][Full Text] [Related]
5. Improving the bioavailability and anticancer effect of the PCA-1/ALKBH3 inhibitor HUHS015 using sodium salt.
Mabuchi M; Shimizu T; Ueda M; Sasakawa Y; Nakao S; Ueda Y; Kawamura A; Tsujikawa K; Tanaka A
In Vivo; 2015; 29(1):39-43. PubMed ID: 25600528
[TBL] [Abstract][Full Text] [Related]
6. DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation.
Dango S; Mosammaparast N; Sowa ME; Xiong LJ; Wu F; Park K; Rubin M; Gygi S; Harper JW; Shi Y
Mol Cell; 2011 Nov; 44(3):373-84. PubMed ID: 22055184
[TBL] [Abstract][Full Text] [Related]
7. Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells
Ueda M; Shimizu T; Mabuchi M; Horiike K; Kitae K; Hase H; Ueda Y; Tsujikawa K; Tanaka A
Anticancer Res; 2018 Jan; 38(1):211-218. PubMed ID: 29277775
[TBL] [Abstract][Full Text] [Related]
8. AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells.
Ueda Y; Ooshio I; Fusamae Y; Kitae K; Kawaguchi M; Jingushi K; Hase H; Harada K; Hirata K; Tsujikawa K
Sci Rep; 2017 Feb; 7():42271. PubMed ID: 28205560
[TBL] [Abstract][Full Text] [Related]
9. Alkbh2 protects against lethality and mutation in primary mouse embryonic fibroblasts.
Nay SL; Lee DH; Bates SE; O'Connor TR
DNA Repair (Amst); 2012 May; 11(5):502-10. PubMed ID: 22429847
[TBL] [Abstract][Full Text] [Related]
10. TP53 gene status is a critical determinant of phenotypes induced by ALKBH3 knockdown in non-small cell lung cancers.
Kogaki T; Ohshio I; Kawaguchi M; Kimoto M; Kitae K; Hase H; Ueda Y; Jingushi K; Tsujikawa K
Biochem Biophys Res Commun; 2017 Jun; 488(2):285-290. PubMed ID: 28479246
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.
Shimada K; Nakamura M; Ishida E; Higuchi T; Yamamoto H; Tsujikawa K; Konishi N
Cancer Sci; 2008 Jan; 99(1):39-45. PubMed ID: 17970783
[TBL] [Abstract][Full Text] [Related]
12. A real-time PCR-based quantitative assay for 3-methylcytosine demethylase activity of ALKBH3.
Ueda Y; Kitae K; Ooshio I; Fusamae Y; Kawaguchi M; Jingushi K; Harada K; Hirata K; Tsujikawa K
Biochem Biophys Rep; 2016 Mar; 5():476-481. PubMed ID: 28955855
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.
Nakao S; Mabuchi M; Shimizu T; Itoh Y; Takeuchi Y; Ueda M; Mizuno H; Shigi N; Ohshio I; Jinguji K; Ueda Y; Yamamoto M; Furukawa T; Aoki S; Tsujikawa K; Tanaka A
Bioorg Med Chem Lett; 2014 Feb; 24(4):1071-4. PubMed ID: 24461353
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer.
Takahashi S; Uemura H; Seeni A; Tang M; Komiya M; Long N; Ishiguro H; Kubota Y; Shirai T
Prostate; 2012 Oct; 72(14):1559-72. PubMed ID: 22430461
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker.
Beharry AA; Lacoste S; O'Connor TR; Kool ET
J Am Chem Soc; 2016 Mar; 138(11):3647-50. PubMed ID: 26967262
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
You Z; Shi XB; DuRaine G; Haudenschild D; Tepper CG; Lo SH; Gandour-Edwards R; de Vere White RW; Reddi AH
Cancer Res; 2006 Jan; 66(1):175-83. PubMed ID: 16397230
[TBL] [Abstract][Full Text] [Related]
17. Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents.
Wang P; Wu J; Ma S; Zhang L; Yao J; Hoadley KA; Wilkerson MD; Perou CM; Guan KL; Ye D; Xiong Y
Cell Rep; 2015 Dec; 13(11):2353-2361. PubMed ID: 26686626
[TBL] [Abstract][Full Text] [Related]
18. DNA repair is indispensable for survival after acute inflammation.
Calvo JA; Meira LB; Lee CY; Moroski-Erkul CA; Abolhassani N; Taghizadeh K; Eichinger LW; Muthupalani S; Nordstrand LM; Klungland A; Samson LD
J Clin Invest; 2012 Jul; 122(7):2680-9. PubMed ID: 22684101
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2.
Shetty A; Dasari S; Banerjee S; Gheewala T; Zheng G; Chen A; Kajdacsy-Balla A; Bosland MC; Munirathinam G
Urol Oncol; 2016 Nov; 34(11):483.e1-483.e8. PubMed ID: 27692835
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
